Given the strong regional heterogeneity of Aβ and tau accumulation in primary and secondary tauopathies, we applied a multi-regional regression model to investigate the detailed associations of ATN biomarker alterations with microglia activation at the individual patient level (Fig. 2A). Here, MAPT is linked to tauopathy.